LINC-ROR and endometrial cancer: Linc-ROR/miRNA axis-mediated SOX9 activation might not be the only mechanism for regulating cancer stemness in ESCC, given that miR-145 has also been reported to enhance aggressive phenotypes by targeting NANOG in pancreatic and endometrial cancer [15, 35].